Managing Mounjaro-Induced Constipation with Miralax
Start Miralax (polyethylene glycol 3350) 17 grams once daily mixed in 8 ounces of liquid to treat constipation caused by Mounjaro (tirzepatide). This is the evidence-based first-line pharmacologic approach for managing this common GLP-1 receptor agonist side effect.
Why This Works
Constipation is a recognized adverse reaction occurring in ≥5% of patients taking Mounjaro 1. The 2023 AGA-ACG guidelines provide a strong recommendation for using PEG 3350 (Miralax) to manage constipation, with moderate certainty of evidence 2.
Evidence Supporting This Approach
PEG 3350 demonstrates robust efficacy:
- Increases complete spontaneous bowel movements by 2.90 per week compared to placebo 2
- Increases spontaneous bowel movements by 2.30 per week 2
- Achieves treatment response in 52% of patients versus 11% with placebo over 6 months 3
- Provides sustained improvement with durable response over 6 months 2
Dosing Algorithm
Starting dose: 17 grams (one capful or packet) once daily
- Mix in 8 ounces of any beverage
- Take at any time of day, with or without food
- Can be taken alongside Mounjaro without timing restrictions
If inadequate response after 1 week:
- Continue at 17 grams daily (most patients respond within the first week)
- Do not exceed recommended dose without physician guidance
- Response typically occurs within 2-4 days of initiation
Clinical Considerations
Expected side effects (generally mild and decrease after first week):
- Bloating, flatulence, or loose stools 2
- Diarrhea occurs more commonly than placebo but is usually mild 2
- Nausea, abdominal distension 2
Safety profile:
- No significant differences in serious adverse events versus placebo 2
- No electrolyte disturbances or laboratory abnormalities in long-term studies 3
- Safe for extended use beyond 6 months 2
Common Pitfalls to Avoid
Inadequate fluid intake: Always mix with full 8 ounces of liquid. Patients with low baseline fluid intake should increase overall daily fluid consumption 2
Premature discontinuation: GI side effects are most common in the first week and typically diminish with continued use 4
Expecting immediate results: While some patients respond within 24-48 hours, full therapeutic effect may take up to one week
Not addressing the underlying cause: Mounjaro delays gastric emptying 1, which contributes to constipation. This is a medication side effect, not chronic idiopathic constipation, but the treatment approach is identical
Alternative or Adjunctive Approaches
If Miralax alone is insufficient:
- Consider adding fiber supplementation (psyllium) if dietary fiber intake is low 2
- Magnesium oxide 1.5 grams daily can be added (avoid in renal insufficiency) 2
For mild constipation before escalating to Miralax:
- A trial of fiber supplementation alone may be attempted, though PEG is more effective 2
- However, given that this is medication-induced constipation from Mounjaro, starting directly with PEG 3350 is reasonable and supported by guidelines 2
Duration of Treatment
Continue Miralax for as long as you remain on Mounjaro, as the constipation is a direct consequence of the medication's mechanism (delayed gastric emptying) 1. Studies demonstrate safety and efficacy for at least 6 months of continuous use 2, 3, and the guidelines note that longer-term use is appropriate 2.